Description
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) needs a direct replacement for an aging dual‑chamber cell incubator used for Dictyostelium cell line culture. The new system must maintain 20‑24 °C, include a temperature‑controlled backup, support a 70‑lb shaker, and integrate a computer‑controlled real‑time imaging system. NIH intends to award a non‑competitive contract to Percival Scientific Incorporated under the simplified acquisition threshold (≤ $350 k). Interested parties may submit capability statements, technical and cost proposals by the September 2, 2026 deadline.
• Replacement incubator with dual chambers and backup temperature control
• Must accommodate a 70‑lb shaker and real‑time imaging computer system
• Compliance with NIH procurement rules (FAR Part 13, NAICS 334516)
• Single‑source award to Percival Scientific Inc. (Perry, IA)
• Submission deadline: 9 AM ET, September 2, 2026; all responders must be SAM‑registered
• Estimated contract value ≤ $350,000
Attached files
Contact
Vishnuvajjala Hanumanth Rao(Lead Purchasing Agent)